Lake Street initiated coverage of Sensus Healthcare (SRTS) with a Buy rating and $18 price target Sensus’ superficial radiation therapy is a non-invasive treatment with no surgical scarring or need ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Lake Street Capital started coverage on shares of Sensus Healthcare (NASDAQ:SRTS – Free Report) in a research report released on Friday, Ratings reports. The firm issued a buy rating and a $18.00 ...

Analysts at Roth Capital issued their FY2028 earnings per share (EPS) estimates for shares of Sensus Healthcare in a research note issued to investors on Thursday, February 6th. Roth Capital analyst J ...

Lake Street Capital Markets initiated coverage on Sensus Healthcare (NASDAQ:SRTS), a medical device company specializing in non-invasive treatments for non-melanoma skin cancer (NMSC) and other skin ...

Multiple options exist for treatment but a newer approach, Image-guided superficial radiation therapy (IGSRT) is a non-invasive treatment that uses advanced imaging to precisely target and treat ...

with a Buy rating and $18 price target Sensus’ superficial radiation therapy is a non-invasive treatment with no surgical scarring or need for reconstructive surgery that allows patients to ...